Cargando…
Primary Processes of Free Radical Formation in Pharmaceutical Formulations of Therapeutic Proteins
Oxidation represents a major pathway for the chemical degradation of pharmaceutical formulations. Few specific details are available on the mechanisms that trigger oxidation reactions in these formulations, specifically with respect to the formation of free radicals. Hence, these mechanisms must be...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10376966/ https://www.ncbi.nlm.nih.gov/pubmed/37509177 http://dx.doi.org/10.3390/biom13071142 |
_version_ | 1785079399956086784 |
---|---|
author | Schöneich, Christian |
author_facet | Schöneich, Christian |
author_sort | Schöneich, Christian |
collection | PubMed |
description | Oxidation represents a major pathway for the chemical degradation of pharmaceutical formulations. Few specific details are available on the mechanisms that trigger oxidation reactions in these formulations, specifically with respect to the formation of free radicals. Hence, these mechanisms must be formulated based on information on impurities and stress factors resulting from manufacturing, transportation and storage. In more detail, this article focusses on autoxidation, metal-catalyzed oxidation, photo-degradation and radicals generated from cavitation as a result of mechanical stress. Emphasis is placed on probable rather than theoretically possible pathways. |
format | Online Article Text |
id | pubmed-10376966 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-103769662023-07-29 Primary Processes of Free Radical Formation in Pharmaceutical Formulations of Therapeutic Proteins Schöneich, Christian Biomolecules Review Oxidation represents a major pathway for the chemical degradation of pharmaceutical formulations. Few specific details are available on the mechanisms that trigger oxidation reactions in these formulations, specifically with respect to the formation of free radicals. Hence, these mechanisms must be formulated based on information on impurities and stress factors resulting from manufacturing, transportation and storage. In more detail, this article focusses on autoxidation, metal-catalyzed oxidation, photo-degradation and radicals generated from cavitation as a result of mechanical stress. Emphasis is placed on probable rather than theoretically possible pathways. MDPI 2023-07-17 /pmc/articles/PMC10376966/ /pubmed/37509177 http://dx.doi.org/10.3390/biom13071142 Text en © 2023 by the author. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Schöneich, Christian Primary Processes of Free Radical Formation in Pharmaceutical Formulations of Therapeutic Proteins |
title | Primary Processes of Free Radical Formation in Pharmaceutical Formulations of Therapeutic Proteins |
title_full | Primary Processes of Free Radical Formation in Pharmaceutical Formulations of Therapeutic Proteins |
title_fullStr | Primary Processes of Free Radical Formation in Pharmaceutical Formulations of Therapeutic Proteins |
title_full_unstemmed | Primary Processes of Free Radical Formation in Pharmaceutical Formulations of Therapeutic Proteins |
title_short | Primary Processes of Free Radical Formation in Pharmaceutical Formulations of Therapeutic Proteins |
title_sort | primary processes of free radical formation in pharmaceutical formulations of therapeutic proteins |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10376966/ https://www.ncbi.nlm.nih.gov/pubmed/37509177 http://dx.doi.org/10.3390/biom13071142 |
work_keys_str_mv | AT schoneichchristian primaryprocessesoffreeradicalformationinpharmaceuticalformulationsoftherapeuticproteins |